TCL Archive Guest Editorial: Nobel Laureates Offer Simple Formula To Save CPRIT From “Infamy and Irrelevance” October 19, 2012
TCL Archive DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million February 27, 1987
TCL Archive ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals September 20, 2013